name:-0.047345161437988
name:-0.029740810394287
name:-0.01469898223877
Meyer; Christophe Patent Filings

Meyer; Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meyer; Christophe.The latest application filed is for "method and device for migrating data traffic from an existing optical wdm transmission system to a new optical wdm transmission system".

Company Profile
15.36.45
  • Meyer; Christophe - Les Authieux sur le Port St Ouen FR
  • Meyer; Christophe - Meiningen DE
  • Meyer; Christophe - Issy-les Moulineaux FR
  • Meyer; Christophe - New York NY
  • Meyer; Christophe - Les Authieux sur le Port Saint Ouer FR
  • MEYER; Christophe - Issy-les Moulineaux Cedex FR
  • Meyer; Christophe - Nancy FR
  • Meyer; Christophe - Issy-les Moulineaux Cedex 9 FR
  • Meyer; Christophe - Issy-les Moulirseaux Cedex 9 FR
  • MEYER; Christophe - Les Authieux sur le Port Saint Ouen FR
  • Meyer; Christophe - Roissy en France FR
  • Meyer; Christophe - Les Authieux sur le Port Sain Quen FR
  • Meyer; Christophe - Les Authieux sur le Port Sain Ouen FR
  • Meyer; Christophe - Les Authieux sur le Port Saint FR
  • Meyer; Christophe - Les Authieux s/l Port St Quen FR
  • Meyer; Christophe - Velizy Cedex FR
  • Meyer; Christophe - Les Authieux s/l Port St Ouen FR
  • Meyer; Christophe - Port St Ouen FR
  • Meyer; Christophe - Les Authieux sur le Port Saint Quen FR
  • Meyer; Christophe - Val de Reuil Cedex FR
  • Meyer; Christophe - Les Authieux s/1 Port St Ouen FR
  • Meyer; Christophe - Les Authieux FR
  • Meyer, Christophe - Lannion FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquin- oxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity
Grant 11,267,804 - Angibaud , et al. March 8, 2
2022-03-08
Method and device for migrating data traffic from an existing optical WDM transmission system to a new optical WDM transmission system
Grant 11,233,564 - Hinderthur , et al. January 25, 2
2022-01-25
Method and Device for Migrating Data Traffic from an Existing Optical WDM Transmission System to a New Optical WDM Transmission System
App 20220014267 - Hinderthur; Henning ;   et al.
2022-01-13
Method And Apparatus For Management Of A Spectral Capacity Of A Wavelength Division Multiplexing System
App 20210409847 - Hinderthur; Henning ;   et al.
2021-12-30
Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors
Grant 11,130,751 - Angibaud , et al. September 28, 2
2021-09-28
Methods And Apparatuses For Pulsed Wave Doppler Ultrasound Imaging
App 20210153846 - Bellamkonda; Kirthi ;   et al.
2021-05-27
Cosmetic compositions and method of treating the skin
Grant 10,980,725 - Brun , et al. April 20, 2
2021-04-20
Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors
Grant 10,894,793 - Berthelot , et al. January 19, 2
2021-01-19
Quinoxaline And Pyridopyrazine Derivatives As Pi3k-beta Inhibitors
App 20200181132 - Angibaud; Patrick Rene ;   et al.
2020-06-11
Methods And Apparatuses For Ultrasound Imaging Using Different Image Formats
App 20200129151 - Neben; Abraham ;   et al.
2020-04-30
Methods And Apparatus For Collecting Color Doppler Ultrasound Data
App 20200129156 - Elgena; David ;   et al.
2020-04-30
Quinoxaline And Pyridopyrazine Derivatives As A Pi3kb Inhibitors
App 20200079763 - Angibaud; Patrick Rene ;   et al.
2020-03-12
Method for determining a personalized cardiac model using a magnetic resonance imaging sequence
Grant 10,548,494 - Meyer , et al. Fe
2020-02-04
Quinoxaline and pyridopyrazine derivatives as PI3K.beta. inhibitors
Grant 10,526,316 - Angibaud , et al. J
2020-01-07
Methods And Apparatus For Configuring An Ultrasound System With Imaging Parameter Values
App 20190307428 - Silberman; Nathan ;   et al.
2019-10-10
Wavelength division multiplexed telecommunication system with automatic compensation of chromatic dispersion
Grant 10,404,397 - Alfiad , et al. Sep
2019-09-03
Azabenzimidazole Derivatives As Pi3k Beta Inhibitors
App 20190263804 - Pilatte; Isabelle Noelle Constance ;   et al.
2019-08-29
Bicyclic Pyridine, Pyrazine, And Pyrimidine Derivatives As Pi3k Beta Inhibitors
App 20190169199 - Berthelot; Didier Jean-Claude ;   et al.
2019-06-06
Methods And Apparatus For Configuring An Ultrasound Device With Imaging Parameter Values
App 20190142388 - Gonyeau; Brenda ;   et al.
2019-05-16
Cosmetic Compositions And Method Of Treating The Skin
App 20190091122 - BRUN; Cecilia ;   et al.
2019-03-28
Quinoxaline And Pyridopyrazine Derivatives As Pi3kb Inhibitors
App 20190062311 - Angibaud; Patrick Rene ;   et al.
2019-02-28
Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors
Grant 10,202,387 - Mevellec , et al. Feb
2019-02-12
Imidazolin-5-one Derivative Useful As Fasn Inhibitors For The Treatment Of Cancer
App 20180327401 - Connolly; Peter J. ;   et al.
2018-11-15
Method and apparatus for automatic compensation of chromatic dispersion
Grant 10,122,460 - Alfiad , et al. November 6, 2
2018-11-06
Imidazopyridazine derivatives as PI3KB inhibitors
Grant 10,087,187 - Mevellec , et al. October 2, 2
2018-10-02
Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
Grant 10,077,261 - Connolly , et al. September 18, 2
2018-09-18
Method And Apparatus For Automatic Compensation Of Chromatic Dispersion
App 20180205461 - ALFIAD; Mohammad ;   et al.
2018-07-19
Heterocyclyl Linked Imidazopyridazine Derivatives As Pi3kb Inhibitors
App 20180057496 - Mevellec; Laurence Anne ;   et al.
2018-03-01
Imidazopyridazine Derivatives As Pi3kb Inhibitors
App 20180002336 - Mevellec; Laurence Anne ;   et al.
2018-01-04
Wavelength division multiplexed telecommunication system with automatic compensation of chromatic dispersion
App 20170187482 - Alfiad; Mohammad ;   et al.
2017-06-29
Cyclopropylboronic compounds, preparation process thereof and use thereof
Grant 9,527,798 - Oosting , et al. December 27, 2
2016-12-27
Method For Determining A Personalized Cardiac Model Using A Magnetic Resonance Imaging Sequence
App 20160324427 - MEYER; Christophe ;   et al.
2016-11-10
Imidazolin-5-one Derivative Useful As Fasn Inhibitors For The Treatment Of Cancer
App 20160002219 - Connolly; Peter J. ;   et al.
2016-01-07
Tetrahydrophenanthridinones And Tetrahydrocyclopentaquinolinones As Parp And Tubulin Polymerization Inhibitors
App 20150353526 - Angibaud; Patrick Rene ;   et al.
2015-12-10
Cyclopropylboronic Compounds, Method For Preparing Same And Use Thereof
App 20150329566 - OOSTING; Peter ;   et al.
2015-11-19
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
Grant 9,150,540 - Angibaud , et al. October 6, 2
2015-10-06
Tetrahydrophenanthridinones And Tetrahydrocyclopentaquinolinones As Parp And Tubulin Polymerization Inhibitors
App 20150038521 - Angibaud; Patrick Rene ;   et al.
2015-02-05
Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
Grant 8,889,866 - Angibaud , et al. November 18, 2
2014-11-18
Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
Grant 8,883,837 - Bonfanti , et al. November 11, 2
2014-11-11
Quinolinone derivatives as PARP and tank inhibitors
Grant 8,778,966 - Vialard , et al. July 15, 2
2014-07-15
Inhibitors of the interaction between MDM2 and P53
Grant 8,404,683 - Lacrampe , et al. March 26, 2
2013-03-26
Quinolinone derivatives as PARP inhibitors
Grant 8,404,713 - Angibaud , et al. March 26, 2
2013-03-26
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53
Grant 8,377,961 - Lacrampe , et al. February 19, 2
2013-02-19
Quinolinone Derivatives As Parp And Tank Inhibitors
App 20130018017 - VIALARD; Jorge Eduardo ;   et al.
2013-01-17
Quinolinone derivatives as PARP and TANK inhibitors
Grant 8,299,256 - Vialard , et al. October 30, 2
2012-10-30
Method For Simulating Behavior In A Reconfigurable Infrastructure And System Implementing Said Method
App 20120265505 - Meyer; Christophe ;   et al.
2012-10-18
5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
Grant 8,278,455 - Bonfanti , et al. October 2, 2
2012-10-02
Inhibitors of the interaction between MDM2 and P53
Grant 8,232,298 - Lacrampe , et al. July 31, 2
2012-07-31
Quinazolinone derivatives as tubulin polymerization inhibitors
Grant 8,168,644 - Freyne , et al. May 1, 2
2012-05-01
Cyclic-alkylamine Derivatives As Inhibitors Of The Interaction Between Mdm2 And P53
App 20120071508 - Lacrampe; Jean Fernand Armand ;   et al.
2012-03-22
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53
Grant 8,088,795 - Lacrampe , et al. January 3, 2
2012-01-03
Tetrahydrophenanthridinones And Tetrahydrocyclopentaquinolinones As Parp And Tubulin Polymerization Inhibitors
App 20110263622 - Angibaud; Patrick Rene ;   et al.
2011-10-27
Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
Grant 8,044,073 - Bonfanti , et al. October 25, 2
2011-10-25
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
Grant 7,943,635 - Angibaud , et al. May 17, 2
2011-05-17
Inhibitors of the Interaction Between MDM2 and P53
App 20110053937 - Lacrampe; Jean Fernand Armand ;   et al.
2011-03-03
Quinazolinone Derivatives As Tubulin Polymerization Inhibitors
App 20110028433 - Freyne; Eddy Jean Edgard ;   et al.
2011-02-03
Inhibitors of the interaction between MDM2 and p53
Grant 7,834,016 - Lacrampe , et al. November 16, 2
2010-11-16
Quinolinone Derivatives As Parp Inhibitors
App 20100222348 - Angibaud; Patrick Rene ;   et al.
2010-09-02
Quinolinone Derivatives As Parp And Tank Inhibitors
App 20100168065 - Vialard; Jorge Eduardo ;   et al.
2010-07-01
Cyclic-alkylamine Derivatives As Inhibitors Of The Interaction Between Mdm2 And P53
App 20100168163 - Lacrampe; Jean Fernand Armand ;   et al.
2010-07-01
Inhibitors Of The Interaction Between Mdm2 And P53
App 20090149493 - Lacrampe; Jean Fernand Armand ;   et al.
2009-06-11
5- Or 6-substituted Benzimidazole Derivatives As Inhibitors Of Respiratory Syncytial Virus Replication
App 20090062278 - Bonfanti; Jean-Francois ;   et al.
2009-03-05
Morpholinyl Containing Benzimidazoles As Inhibitors Of Respiratory Syncytial Virus Replication
App 20080280881 - Bonfanti; Jean-Francois ;   et al.
2008-11-13
Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
Grant 7,449,463 - Bonfanti , et al. November 11, 2
2008-11-11
Benzylimidazolyl Substituted 2-quinoline And Quinazoline Derivatives For Use As Farnesyl Transferase Inhibitors
App 20080255191 - Angibaud; Patrick Rene ;   et al.
2008-10-16
Inhibitors of the Interaction Between Mdm2 and P53
App 20080039472 - Lacrampe; Jean Fernand Armand ;   et al.
2008-02-14
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
Grant 7,241,777 - Angibaud , et al. July 10, 2
2007-07-10
5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
App 20070093502 - Bonfanti; Jean-Francois ;   et al.
2007-04-26
Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
App 20070043022 - Bonfanti; Jean-Francois ;   et al.
2007-02-22
Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
App 20050171111 - Angibaud, Patrick Rene ;   et al.
2005-08-04
Polarization alternating transmission systems, apparatuses, and methods
App 20050111849 - Merlaud, Fabien ;   et al.
2005-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed